We serve Chemical Name:4-(2,4-dimethoxyphenyl)-5-methylpyrazolidin-3-amine CAS:863550-42-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(2,4-dimethoxyphenyl)-5-methylpyrazolidin-3-amine
CAS.NO:863550-42-9
Synonyms:4-(2,4-dimethoxyphenyl)-5-methylpyrazolidin-3-amine
Molecular Formula:C12H15N3O2
Molecular Weight:233.26600
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:73.16000
Exact Mass:233.11600
LogP:2.56570
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-(2,4-dimethoxyphenyl)-5-methylpyrazolidin-3-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(2,4-dimethoxyphenyl)-5-methylpyrazolidin-3-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(2,4-dimethoxyphenyl)-5-methylpyrazolidin-3-amine Use and application,4-(2,4-dimethoxyphenyl)-5-methylpyrazolidin-3-amine technical grade,usp/ep/jp grade.
Related News: It’s a disturbing set of events, scientifically, clinically, politically, Karlawish said. 4-(2,4-dimethoxyphenyl)-5-methylpyrazolidin-3-amine manufacturer The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. 4-(2,4-dimethoxyphenyl)-5-methylpyrazolidin-3-amine supplier Like Altasciences, Alira has also placed an emphasis on the preclinical setting in recent months with its March hire of Nikole Siegmund as vice president of preclinical development. 4-(2,4-dimethoxyphenyl)-5-methylpyrazolidin-3-amine vendor It’s a disturbing set of events, scientifically, clinically, politically, Karlawish said. 4-(2,4-dimethoxyphenyl)-5-methylpyrazolidin-3-amine factory Like Altasciences, Alira has also placed an emphasis on the preclinical setting in recent months with its March hire of Nikole Siegmund as vice president of preclinical development.
